U.S FDA has accepted IND application for COMP360 in PTSD, enabling the initiation of a Phase 2b/3 (COMP202) clinical trial in patients living with PTSD.

Shares of Compass Pathways Plc (NASDAQ:CMPS) rose about 3% in premarket trading on Wednesday after the company said the U.S. Food and Drug Administration has accepted its Investigational New Drug (IND ...

Compass Pathways has entered its seventh U.S. strategic collaboration with Radial Health. Radial Health operates in five ...

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation announced today it is entering into its seventh strategic ...

纽约/伦敦 - 生物技术公司 Compass Pathways plc (NASDAQ:CMPS) 周二宣布与全国性介入精神病学实践网络Radial Health, Inc.建立战略合作关系，这标志着其第七个此类合作伙伴关系。据 InvestingPro 数据显示，这家市值约6.3亿美元的生物技术公司在过去六个月内股价飙升超过101%。

The company is also advancing commercial preparations for COMP360 in treatment-resistant depression (TRD), aiming to be launch-ready by the end of the year if approved. Compass recently held a ...

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation announced today it is entering into its seventh strategic collaborati ...

Application for COMP360 for the treatment of post-traumatic stress disorder (PTSD), enabling initiation of late-stage trial Compass continues to ...

Compass Pathways (CMPS), on Wednesday, said the U.S. Food and Drug Administration (FDA) has accepted its Investigational New ...

Investing.com -- 周三盘前交易中， Compass Pathways Plc (NASDAQ:CMPS) 股价上涨3%，此前该公司宣布美国食品药品监督管理局已接受其COMP360的研究性新药申请，使其能够开始对创伤后应激障碍患者进行后期临床试验。

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the first quarter: Alumis: Top-line ...

D.C.-based Compass Coffee has filed for Chapter 11 bankruptcy protection as it restructures parts of its business.